1. Stereospecific total synthesis of 9-aminoanthracyclines: (+)-9-amino-9-deoxydaunomycin and related compounds;Ishizumi;J. Org. Chem.,1987
2. Antitumor activities of a novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenografts;Morisada;Jpn. J. Cancer Res.,1989
3. and The West Japan Lung Cancer Group. Phase II study of amrubicin (SM-5887), a novel 9-aminoanthracycline, in previously untreated patients with extensive-stage small-cell lung cancer (ES-SCLC): a trial of The West Japan Lung Cancer Group;Yokota;8th World Conference on Lung Cancer,1997
4. and The SM-5887 Lung Cancer Study Group. A phase II of SM-5887, a novel 9-aminoanthracycline, for non-small cell lung cancer;Hiraki;18th International Congress of Chemotherapy,1993
5. Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines;Takigawa;Acta Med. Okayama,1992